Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The CanACT and the ReACT trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 1, 2005